166 related articles for article (PubMed ID: 1837045)
1. [Hypercalcemia in malignancy].
Eto S
Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1534-9. PubMed ID: 1837045
[No Abstract] [Full Text] [Related]
2. [Physiopathology and therapy of hypercalcemia associated with malignancies].
Ikeda K
Nihon Naika Gakkai Zasshi; 1999 Jul; 88(7):1212-7. PubMed ID: 10465966
[No Abstract] [Full Text] [Related]
3. [Malignancy associated with hypercalcemia].
Eto S
Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):371-6. PubMed ID: 8690997
[No Abstract] [Full Text] [Related]
4. [Hypercalcemia therapy in malignant tumors].
Bruntsch U
MMW Munch Med Wochenschr; 1979 Jan; 121(1):16-8. PubMed ID: 152868
[No Abstract] [Full Text] [Related]
5. Hypercalcaemia due to malignancy. Role of the kidney and treatment.
Sleeboom HP; Bijvoet OL
Contrib Nephrol; 1982; 33():178-96. PubMed ID: 6214375
[No Abstract] [Full Text] [Related]
6. Medical management of the hypercalcemia of malignancy.
Deftos LJ; Neer R
Annu Rev Med; 1974; 25(0):323-31. PubMed ID: 4277568
[No Abstract] [Full Text] [Related]
7. Treatment of hypercalcemia associated with malignancy.
Mazzaferri EL; O'Dorisio TM; LoBuglio AF
Semin Oncol; 1978 Jun; 5(2):141-53. PubMed ID: 150032
[No Abstract] [Full Text] [Related]
8. Symptomatic hypocalcemia following combined calcitonin and mithramycin therapy for hypercalcemia due to malignancy.
Caro JF; Besarab A; Glennon JA
Cancer Treat Rep; 1978 Oct; 62(10):1561-3. PubMed ID: 152145
[TBL] [Abstract][Full Text] [Related]
9. [Progress in therapy and diagnosis: Hypercalcemia due to parathyroid hormone-related protein producing neoplasms].
Tanaka Y; Okada Y
Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):669-74. PubMed ID: 17506302
[No Abstract] [Full Text] [Related]
10. Acute management of cancer-related hypercalcemia.
Chisholm MA; Mulloy AL; Taylor AT
Ann Pharmacother; 1996 May; 30(5):507-13. PubMed ID: 8740333
[TBL] [Abstract][Full Text] [Related]
11. Drug therapy of hypercalcemia due to malignancy.
Raue F; Pecherstorfer M
Recent Results Cancer Res; 1994; 137():138-60. PubMed ID: 7878293
[No Abstract] [Full Text] [Related]
12. [Treatment of malignancy-associated hypercalcemia].
Endo I; Inoue D
Clin Calcium; 2006 Apr; 16(4):665-69. PubMed ID: 16582519
[TBL] [Abstract][Full Text] [Related]
13. [Hypercalcemia: causes, symptoms and therapy].
Kuipers M
Med Monatsschr Pharm; 1986 Jan; 9(1):16-7. PubMed ID: 2936946
[No Abstract] [Full Text] [Related]
14. [Treatment of severe hypercalcemia].
Godin M; Fillastre JP
Rev Prat; 1978 Sep; 28(41):3133-4, 3137-8, 3141. PubMed ID: 152451
[No Abstract] [Full Text] [Related]
15. [Parathyroid hormone-related peptide induced humoral hypercalcemia of malignancy].
Tfelt-Hansen J; Brixen KT; Mosekilde L; Schwarz P
Ugeskr Laeger; 2005 Feb; 167(8):924-6. PubMed ID: 15789851
[No Abstract] [Full Text] [Related]
16. Hypercalcaemia. Management.
Selby PC; Peacock M; Marshall DH
Br J Hosp Med; 1984 Mar; 31(3):186, 188, 190 passim. PubMed ID: 6324944
[No Abstract] [Full Text] [Related]
17. Calcitonin treatment of hypercalcemia due to parathyroid carcinoma. Synergistic effect of prednisone on long-term treatment of hypercalcemia.
Au WY
Arch Intern Med; 1975 Dec; 135(12):1594-7. PubMed ID: 128332
[No Abstract] [Full Text] [Related]
18. [Etiology and therapy of hypercalcemia].
Fujita T
Nihon Rinsho; 1992 Jan; 50 Suppl():404-9. PubMed ID: 1533694
[No Abstract] [Full Text] [Related]
19. Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment.
Mosekilde L; Eriksen EF; Charles P
Crit Rev Oncol Hematol; 1991; 11(1):1-27. PubMed ID: 1883526
[TBL] [Abstract][Full Text] [Related]
20. [Pathophysiology and treatment of malignancy-associated hypercalcemia].
Miyauchi A
Nihon Rinsho; 2006 Jun; Suppl 2():161-4. PubMed ID: 16817374
[No Abstract] [Full Text] [Related]
[Next] [New Search]
